
Sotera Health (SHC) Stock Forecast & Price Target
Sotera Health (SHC) Analyst Ratings
Bulls say
Sotera Health is expected to see continued growth in all three segments, with management demonstrating strong leadership through a strategic planning process and an emphasis on talent, customer partnerships, and cross-business offerings. With a solid start to 2026 and the CEO succession plan being well-managed, the company is poised for strong performance and growth consistency, making it a good investment opportunity at current levels.
Bears say
Sotera Health is facing several legal challenges, including a recent settlement for an "immaterial" amount in a New Mexico public nuisance case, and ongoing trials in Georgia and California. While management remains confident in their litigate-with-science and settle modestly strategy, the continuous legal risks and potential financial implications for the company may weigh on the stock's valuation. Additionally, while the company's Sterigenics segment has shown growth, intensive competition in the industry and potential regulatory hurdles could impede future growth prospects.
This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.
Sotera Health (SHC) Analyst Forecast & Price Prediction
Start investing in Sotera Health (SHC)
Order type
Buy in
Order amount
Est. shares
0 shares